A study on hereditary breast cancer/ovarian cancer revealed that the mutations in BRCA1, BRCA2, RAD51, PALB2, and PRIP1 are associated with the ICL repair pathways (34). The gene discussed is BRCA2; the disease is ovarian carcinoma.